Palladiem’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$1.86M Sell
38,450
-295
-0.8% -$15.7K 2.01% 19
2023
Q2
$2.19M Buy
38,745
+2
+0% +$110 2.25% 17
2023
Q1
$2.09M Sell
38,743
-950
-2% -$50.6K 2.23% 14
2022
Q4
$2.09M Sell
39,693
-1,143
-3% -$58K 2.17% 16
2022
Q3
$1.93M Sell
40,836
-925
-2% -$48K 2.02% 16
2022
Q2
$2.11M Sell
41,761
-297
-0.7% -$16.2K 2.09% 15
2022
Q1
$2.56M Sell
42,058
-14,046
-25% -$837K 2.27% 16
2021
Q4
$3.69M Buy
56,104
+1,338
+2% +$85.7K 2.97% 13
2021
Q3
$3.44M Buy
54,766
+5,716
+12% +$365K 2.78% 13
2021
Q2
$2.95M Buy
49,050
+6,258
+15% +$362K 2.38% 14
2021
Q1
$2.36M Buy
+42,792
New +$2.37M 2.06% 14

Other funds holding IHI

Palladiem's IHI Position: Q3 2023 in Review

Palladiem reduced its iShares US Medical Devices ETF (IHI) stake by 0.76% in Q3 2023, selling an estimated $15.7K and leaving 38,450 shares worth $1.86M. The position accounts for 2.01% of the portfolio, ranked #19.

Palladiem first reported a position in IHI in Q1 2021 and has held it in 11 quarters since. The position peaked at $3.69M in Q4 2021. 544 funds tracked by Wall St. Rank hold IHI as of Q3 2023.

  • Palladiem held 38,450 shares of iShares US Medical Devices ETF worth $1.86M as of Q3 2023.
  • Palladiem sold 295 iShares US Medical Devices ETF shares in Q3 2023, an estimated $15.7K.
  • iShares US Medical Devices ETF made up 2.01% of Palladiem's portfolio in Q3 2023, its #19 holding.
  • Palladiem first reported a position in iShares US Medical Devices ETF in Q1 2021 and has held it in 11 quarters since.
  • Palladiem's iShares US Medical Devices ETF position peaked at $3.69M in Q4 2021.
  • 544 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2023.

Based on Palladiem's 13F filing for Q3 2023, filed 8 Dec 2023.